Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 287

1.

ARF represses androgen receptor transactivation in prostate cancer.

Lu W, Xie Y, Ma Y, Matusik RJ, Chen Z.

Mol Endocrinol. 2013 Apr;27(4):635-48. doi: 10.1210/me.2012-1294. Epub 2013 Feb 28.

2.

Krüppel-like factor 8 is a novel androgen receptor co-activator in human prostate cancer.

He HJ, Gu XF, Xu WH, Yang DJ, Wang XM, Su Y.

Acta Pharmacol Sin. 2013 Feb;34(2):282-8. doi: 10.1038/aps.2012.130. Epub 2012 Oct 1.

3.
4.

Mechanism of androgen receptor corepression by CKβBP2/CRIF1, a multifunctional transcription factor coregulator expressed in prostate cancer.

Tan JA, Bai S, Grossman G, Titus MA, Ford OH, Pop EA, Smith GJ, Mohler JL, Wilson EM, French FS.

Mol Cell Endocrinol. 2014 Jan 25;382(1):302-13. doi: 10.1016/j.mce.2013.09.036. Epub 2013 Oct 5.

5.

Increased PrLZ-mediated androgen receptor transactivation promotes prostate cancer growth at castration-resistant stage.

Li L, Xie H, Liang L, Gao Y, Zhang D, Fang L, Lee SO, Luo J, Chen X, Wang X, Chang LS, Yeh S, Wang Y, He D, Chang C.

Carcinogenesis. 2013 Feb;34(2):257-67. doi: 10.1093/carcin/bgs337. Epub 2012 Oct 26.

6.

The CCAAT enhancer-binding protein-alpha negatively regulates the transactivation of androgen receptor in prostate cancer cells.

Chattopadhyay S, Gong EY, Hwang M, Park E, Lee HJ, Hong CY, Choi HS, Cheong JH, Kwon HB, Lee K.

Mol Endocrinol. 2006 May;20(5):984-95. Epub 2006 Feb 2.

PMID:
16455820
7.

Post-translational Down-regulation of Melanoma Antigen-A11 (MAGE-A11) by Human p14-ARF Tumor Suppressor.

Minges JT, Grossman G, Zhang P, Kafri T, Wilson EM.

J Biol Chem. 2015 Oct 9;290(41):25174-87. doi: 10.1074/jbc.M115.663641. Epub 2015 Sep 1.

PMID:
26330556
8.

The role of sLZIP in cyclin D3-mediated negative regulation of androgen receptor transactivation and its involvement in prostate cancer.

Kim Y, Kim J, Jang SW, Ko J.

Oncogene. 2015 Jan 8;34(2):226-36. doi: 10.1038/onc.2013.538. Epub 2014 Jan 20.

PMID:
24441043
9.
10.

Peroxisome proliferator-activated receptor gamma coactivator-1alpha interacts with the androgen receptor (AR) and promotes prostate cancer cell growth by activating the AR.

Shiota M, Yokomizo A, Tada Y, Inokuchi J, Tatsugami K, Kuroiwa K, Uchiumi T, Fujimoto N, Seki N, Naito S.

Mol Endocrinol. 2010 Jan;24(1):114-27. doi: 10.1210/me.2009-0302. Epub 2009 Nov 2.

PMID:
19884383
11.

Sterol regulatory element-binding protein-1c represses the transactivation of androgen receptor and androgen-dependent growth of prostatic cells.

Suh JH, Gong EY, Kim JB, Lee IK, Choi HS, Lee K.

Mol Cancer Res. 2008 Feb;6(2):314-24. doi: 10.1158/1541-7786.MCR-07-0354. Epub 2008 Feb 1.

12.

Ligand-dependent corepressor acts as a novel androgen receptor corepressor, inhibits prostate cancer growth, and is functionally inactivated by the Src protein kinase.

Asim M, Hafeez BB, Siddiqui IA, Gerlach C, Patz M, Mukhtar H, Baniahmad A.

J Biol Chem. 2011 Oct 28;286(43):37108-17. doi: 10.1074/jbc.M111.292771. Epub 2011 Aug 19.

13.

p68/DdX5 supports β-catenin & RNAP II during androgen receptor mediated transcription in prostate cancer.

Clark EL, Hadjimichael C, Temperley R, Barnard A, Fuller-Pace FV, Robson CN.

PLoS One. 2013;8(1):e54150. doi: 10.1371/journal.pone.0054150. Epub 2013 Jan 17.

14.

Determinants of Gli2 co-activation of wildtype and naturally truncated androgen receptors.

Li N, Chen M, Truong S, Yan C, Buttyan R.

Prostate. 2014 Oct;74(14):1400-10. doi: 10.1002/pros.22855. Epub 2014 Aug 11.

PMID:
25132524
15.

A natural androgen receptor antagonist induces cellular senescence in prostate cancer cells.

Hessenkemper W, Roediger J, Bartsch S, Houtsmuller AB, van Royen ME, Petersen I, Grimm MO, Baniahmad A.

Mol Endocrinol. 2014 Nov;28(11):1831-40. doi: 10.1210/me.2014-1170. Epub 2014 Sep 9.

PMID:
25203674
16.
17.

CR6-interacting factor 1 represses the transactivation of androgen receptor by direct interaction.

Suh JH, Shong M, Choi HS, Lee K.

Mol Endocrinol. 2008 Jan;22(1):33-46. Epub 2007 Sep 20.

PMID:
17885209
18.

Modulation of androgen receptor transactivation by FoxH1. A newly identified androgen receptor corepressor.

Chen G, Nomura M, Morinaga H, Matsubara E, Okabe T, Goto K, Yanase T, Zheng H, Lu J, Nawata H.

J Biol Chem. 2005 Oct 28;280(43):36355-63. Epub 2005 Aug 23.

19.

Transcription factor Stat5 knockdown enhances androgen receptor degradation and delays castration-resistant prostate cancer progression in vivo.

Thomas C, Zoubeidi A, Kuruma H, Fazli L, Lamoureux F, Beraldi E, Monia BP, MacLeod AR, Thüroff JW, Gleave ME.

Mol Cancer Ther. 2011 Feb;10(2):347-59. doi: 10.1158/1535-7163.MCT-10-0850. Epub 2011 Jan 7.

20.

New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells.

Lai KP, Huang CK, Chang YJ, Chung CY, Yamashita S, Li L, Lee SO, Yeh S, Chang C.

Am J Pathol. 2013 Feb;182(2):460-73. doi: 10.1016/j.ajpath.2012.10.029. Epub 2012 Dec 4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk